These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18062821)

  • 1. Canada's implementation of the Paragraph 6 Decision: is it sustainable public policy?
    Cohen-Kohler JC; Esmail LC; Cosio AP
    Global Health; 2007 Dec; 3():12. PubMed ID: 18062821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The politics behind the implementation of the WTO Paragraph 6 Decision in Canada to increase global drug access.
    Esmail LC; Kohler JC
    Global Health; 2012 Apr; 8():7. PubMed ID: 22472291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime.
    Esmail LC; Phillips K; Kuek V; Cosio AP; Kohler JC
    BMC Int Health Hum Rights; 2010 Jan; 10():1. PubMed ID: 20044940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A one-time-only combination: Emergency medicine exports and the TRIPS agreement under Canada's access to medicines regime.
    Weber A; Mills L
    Health Hum Rights; 2010 Jun; 12(1):109-22. PubMed ID: 20930258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trade-Related Aspects of Intellectual Property Rights Flexibilities and Public Health: Implementation of Compulsory Licensing Provisions into National Patent Legislation.
    McGIVERN L
    Milbank Q; 2023 Dec; 101(4):1280-1303. PubMed ID: 37646392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Panel: Canada's law on global access to affordable medicines.
    Avafia T; Morrison C; Clark B; Kohler JC
    HIV AIDS Policy Law Rev; 2009 Dec; 14(2):76-83. PubMed ID: 20225526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canada's Access to Medicines Regime: Promise or Failure of Humanitarian Effort?
    Kohler JC; Lexchin J; Kuek V; Orbinski J
    Healthc Policy; 2010 Feb; 5(3):40-8. PubMed ID: 21286267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canada and access to medicines in developing countries: intellectual property rights first.
    Lexchin J
    Global Health; 2013 Sep; 9():42. PubMed ID: 24007595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removing barriers? An overview of the Canadian Access to Medicines Regime.
    Penner MD; Armstrong PG
    Health Law Can; 2008 Jun; 28(3-4):112-22. PubMed ID: 19051971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIPS, the Doha Declaration and increasing access to medicines: policy options for Ghana.
    Cohen JC; Gyansa-Lutterodt M; Torpey K; Esmail LC; Kurokawa G
    Global Health; 2005 Dec; 1():17. PubMed ID: 16336685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compulsory patent licensing and local drug manufacturing capacity in Africa.
    Owoeye OA
    Bull World Health Organ; 2014 Mar; 92(3):214-9. PubMed ID: 24700981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lost in translation: the Canadian access to medicines regime from transnational activism to domestic implementation.
    Bubela T; Morin JF
    Health Law J; 2010; 18():113-57. PubMed ID: 22125973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affordability versus innovation: Is compulsory licensing the solution?
    Pandey E; Paul SB
    Int J Risk Saf Med; 2019; 30(4):233-247. PubMed ID: 31658067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIPS from Doha to Cancún ... to Ottawa: global developments in access to treatment and Canada's Bill C-56.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2003 Dec; 8(3):1, 7-18. PubMed ID: 15104062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First test of WTO mechanism for procuring generic medicines under compulsory licence, via Canada's Access to Medicines Regime.
    Elliott R
    HIV AIDS Policy Law Rev; 2007 Dec; 12(2-3):23-5. PubMed ID: 18459195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Learning from practice: compulsory licensing cases and access to medicines.
    Stirner B
    Pharm Pat Anal; 2012 Nov; 1(5):555-75. PubMed ID: 24236925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?
    Dionisio D; Cao Y; Hongzhou L; Kraisintu K; Messeri D
    Curr HIV Res; 2006 Jan; 4(1):3-20. PubMed ID: 16454707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Learning from practice: compulsory licensing cases and access to medicines.
    Stirner B; Thangaraj H
    Pharm Pat Anal; 2013 Mar; 2(2):195-213. PubMed ID: 24237026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.